Trading Tips - koolfriend4u

[koolfriend4u]

Sorry to disagree brother but my guess is exact opposite atleast on Glenmark, btw when you say shortsell I hope you always mean squaring off the position by EOD and not buying Put options etc. coz I too guess @ 275 Glenmark is overbought but doubt if its a good candidate for shortsell today.

I dont do trade often - i do only when something is going to happen thats wat glenmark today too. shorted @ 278 & covered @ 271

 

[koolfriend4u]

Am on HDIL short from 257 for tgt 254 - 251 sl 260

 

[deepakonroll]

koolfriend4u,
GLENMARK moving towards your target.
waiting to pick it at that level.lets see.

 

[vssoma]

healthy discussion...

 

[praveen taneja]

Now all bad news flow in cairn India from insider trading to rumour of production start I am out of it at 249.5 now I am in BVCL from Savant bro advice bonus due next mnth record date 25sep any view on it????

 

[Mangafreakz]

@PT Sir , Can u help me out on This
http://www.traderji.com/equities/31698-suzlon.html#post347216

 

[djsinha]

Now all bad news flow in cairn India from insider trading to rumour of production start I am out of it at 249.5 now I am in BVCL from Savant bro advice bonus due next mnth record date 25sep any view on it????

BVCL is going to fall very soon. Reasons being:

1. It moved up too much from its 50 day moving average and stoch showing -ve divergence.
2. On friday last it made an upthrust bar on very high volumes indicating massive selling have taken place.

Since Savant has recommended BVCL to you, I'm sure it's very good for 1-2 months. But for the next 5-6 days, chances are high that it'll retrace.

Regards
DJ

 

[praveen taneja]

BVCL is going to fall very soon. Reasons being:

1. It moved up too much from its 50 day moving average and stoch showing -ve divergence.
2. On friday last it made an upthrust bar on very high volumes indicating massive selling have taken place.

Since Savant has recommended BVCL to you, I'm sure it's very good for 1-2 months. But for the next 5-6 days, chances are high that it'll retrace.

Regards
DJ

its still at 35.50 and my buying avg is at 35.75 so not in much lower
but cement stock will rise reason is this
1 they are underperformer in this rally which is ending
2.Infra n Road making need cement
3.Savant bro recommended:thumb:
4 On sep 25 book closing for dividend and bonus and AGM on 30th SEP:thumb:
My tgt asomewhere around 50 as have huge quantity
Thnx for suggesting and alert will keep in mind ur advice

 

[djsinha]

its still at 35.50 and my buying avg is at 35.75 so not in much lower
but cement stock will rise reason is this
1 they are underperformer in this rally which is ending
2.Infra n Road making need cement
3.Savant bro recommended:thumb:
4 On sep 25 book closing for dividend and bonus and AGM on 30th SEP:thumb:
My tgt asomewhere around 50 as have huge quantity
Thnx for suggesting and alert will keep in mind ur advice

Hi Praveen

Good analysis by you. BVCL defying the gravitational pull of the broader mkts. It's still in green. Savant ROCKXXXXXX!!!!! :thumb:

Regards
DJ

 

[koolfriend4u]

koolfriend4u,
GLENMARK moving towards your target.
waiting to pick it at that level.lets see.

sorry for this week I cant trade but can do updates i believe...

for glenmark followers

Glenmark Pharmaceuticals has informed that Crofelemer, a potential first in class innovative drug for multiple indicators including HIV- associated diarrhea completed the dose selection stage (Stage I) of the phase III (advent) trial for the treatment of chronic diarrhea in people living with HIV/AIDS on antiretrovial therapies.

The phase III trials in the United States are being conducted by Glenmark`s partners Napo Pharmaceuticals and Salix Pharmaceuticals. The final stage of the Phase III adaptive study will begin in the treatment of chronic diarrhea in patients living with HIV/AIDS.

Commenting on this development, Glenn Saldhana, managing director and chief executive officer (CEO), Glenmark Pharmaceuticals, (Q, N,C,F)* mentioned, ``with Crofelemer progressing to the final stage of phase III trials, we will accelerate the manufacturing scale- up and planning for its anticipated commercial launch. Based on he current progress, we anticipate the launch of Crofelemer in India in CY 2010.``


Shares of of the company gained Rs 7.2, or 2.84%, to trade at Rs 260.30. The total volume of shares traded was 487,895 at the BSE (1.51 p.m., Monday).

Disclosure : i dont have any positions currently on this stock